Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas A Pollak

Showing results (71-80 of 96) with videos related to

Pageof 10
Sort By:
Rheumatology (Oxford, England)|July 26, 2023
Prevalence and identification of neuropsychiatric symptoms in systemic autoimmune rheumatic diseases: an international mixed methods studyMelanie Sloan, Chris Wincup, Rupert Harwood, et al.
Biological Psychiatry|February 4, 2021
Relationship Between Serum NMDA Receptor Antibodies and Response to Antipsychotic Treatment in First-Episode PsychosisThomas A Pollak, Angela Vincent, Conrad Iyegbe, et al.
Rheumatology (Oxford, England)|August 12, 2025
Self-reported cognitive dysfunction and memory impairment in systemic autoimmune rheumatic diseases (SARDs): a mixed methods analysis of the INSPIRE cohortAvni Varshney, Thomas A Pollak, Arjoon Arunasalam, et al.
Psychological Medicine|February 9, 2022
Catatonia: demographic, clinical and laboratory associationsJonathan P Rogers, Thomas A Pollak, Nazifa Begum, et al.
Eclinicalmedicine|March 20, 2026
Two-year follow-up of neuropsychiatric symptoms in patients with systemic autoimmune rheumatic diseases: longitudinal insights on depression, anxiety, memory and adaptation in the INSPIRE cohortMelanie Sloan, Avni Varshney, David D'Cruz, et al.
The Lancet. Psychiatry|September 20, 2024
Clinical symptoms and psychosocial functioning in patients with schizophrenia spectrum disorders testing seropositive for anti-NMDAR antibodies: a case-control comparison with patients testing negativeJurjen J Luykx, Robbert Visscher, Inge Winter-van Rossum, et al.
Translational Psychiatry|January 11, 2022
Immunological causes of obsessive-compulsive disorder: is it time for the concept of an "autoimmune OCD" subtype?Dominique Endres, Thomas A Pollak, Karl Bechter, et al.
Translational Psychiatry|July 24, 2024
An exploratory study of the damage markers NfL, GFAP, and t-Tau, in cerebrospinal fluid and other findings from a patient cohort enriched for suspected autoimmune psychiatric diseaseMikaela Syk, Emma Tornvind, Maike Gallwitz, et al.
Rheumatology (Oxford, England)|March 22, 2024
Neuropsychiatric symptoms in systemic lupus erythematosus: mixed methods analysis of patient-derived attributional evidence in the international INSPIRE projectMelanie Sloan, Thomas A Pollak, Efthalia Massou, et al.
Schizophrenia Research|February 3, 2026
Psychopathology distinguishing secondary ("organic") psychoses: A systematic review and meta-analysisGraham Blackman, Hamilton Morrin, Claire Carstairs, et al.
Pageof 10

Showing results (71-80 of 96) with videos related to

Sort By:
Pageof 10
Rheumatology (Oxford, England)|July 26, 2023
Prevalence and identification of neuropsychiatric symptoms in systemic autoimmune rheumatic diseases: an international mixed methods studyMelanie Sloan, Chris Wincup, Rupert Harwood, et al.
Biological Psychiatry|February 4, 2021
Relationship Between Serum NMDA Receptor Antibodies and Response to Antipsychotic Treatment in First-Episode PsychosisThomas A Pollak, Angela Vincent, Conrad Iyegbe, et al.
Rheumatology (Oxford, England)|August 12, 2025
Self-reported cognitive dysfunction and memory impairment in systemic autoimmune rheumatic diseases (SARDs): a mixed methods analysis of the INSPIRE cohortAvni Varshney, Thomas A Pollak, Arjoon Arunasalam, et al.
Psychological Medicine|February 9, 2022
Catatonia: demographic, clinical and laboratory associationsJonathan P Rogers, Thomas A Pollak, Nazifa Begum, et al.
Eclinicalmedicine|March 20, 2026
Two-year follow-up of neuropsychiatric symptoms in patients with systemic autoimmune rheumatic diseases: longitudinal insights on depression, anxiety, memory and adaptation in the INSPIRE cohortMelanie Sloan, Avni Varshney, David D'Cruz, et al.
The Lancet. Psychiatry|September 20, 2024
Clinical symptoms and psychosocial functioning in patients with schizophrenia spectrum disorders testing seropositive for anti-NMDAR antibodies: a case-control comparison with patients testing negativeJurjen J Luykx, Robbert Visscher, Inge Winter-van Rossum, et al.
Translational Psychiatry|January 11, 2022
Immunological causes of obsessive-compulsive disorder: is it time for the concept of an "autoimmune OCD" subtype?Dominique Endres, Thomas A Pollak, Karl Bechter, et al.
Translational Psychiatry|July 24, 2024
An exploratory study of the damage markers NfL, GFAP, and t-Tau, in cerebrospinal fluid and other findings from a patient cohort enriched for suspected autoimmune psychiatric diseaseMikaela Syk, Emma Tornvind, Maike Gallwitz, et al.
Rheumatology (Oxford, England)|March 22, 2024
Neuropsychiatric symptoms in systemic lupus erythematosus: mixed methods analysis of patient-derived attributional evidence in the international INSPIRE projectMelanie Sloan, Thomas A Pollak, Efthalia Massou, et al.
Schizophrenia Research|February 3, 2026
Psychopathology distinguishing secondary ("organic") psychoses: A systematic review and meta-analysisGraham Blackman, Hamilton Morrin, Claire Carstairs, et al.
Pageof 10